Metabolic disposition of lansoprazole in relation to the S-mephenytoin 4'-hydroxylation phenotype status (Q73369049)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Metabolic disposition of lansoprazole in relation to the S-mephenytoin 4'-hydroxylation phenotype status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

D R Sohn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J T Kwon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

H K Kim

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Ishizaki

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

574-582

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Assessment of liver metabolic function. Clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Genetic polymorphism of S-mephenytoin hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Clinical pharmacokinetics of lansoprazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Determination of lansoprazole and five metabolites in plasma by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Pharmacokinetics of lansoprazole in patients with renal or liver disease of varying severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990137-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(97)90137-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164419%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference